[Fever of Unknown Origin in a Patient Administered With Bacillus Calmette-Guérin (BCG) to Treat Urothelial Vesical Carcinoma in Situ]
Koch’s Bacillus bovis (Mycobacterium bovis) was made avirulent by special culture conditions, i.e., 230 passages on medium containing potatoes treated with bile salts. It has been used mainly to prevent tuberculosis. The vaccine was named after the bacteriologist Albert Calmette and the veterinarian...
Main Authors: | Paolo Ghiringhelli, Federica Macchi, Mariella Ciola, Girolamo Sala, Beatrice Valvo, Andrea Agostinelli, Lorenzo Bellintani, Gaetano Emanuele Rizzo, Michela Provisione, Michela Zaza, Alessandro Diana, Maurizio Ferrarese |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2023-07-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | http://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1543 |
Similar Items
-
Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01) -
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
by: Suleiman Al-Hammadi, et al.
Published: (2017-05-01) -
Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
by: Frédéric Quatannens, et al.
Published: (2022-07-01) -
Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01) -
A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)